Market Access/ Views & Analysis/ Views and analysis VPAS: Progress two years in and opportunities to improve over next three years Leela Barham ABPI, branded medicines, Department of Health & Social Care, NHS, VPAS 0 Comment In the final instalment of our series reviewing the the 2019 Voluntary Scheme for Branded Medicines Pricing and Share X VPAS: Progress two years in and opportunities to improve over next three years https://pharmaphorum.com/views-analysis-market-access/vpas-progress-two-years-in-and-opportunities-to-improve-over-next-three-years/